Package 69097-819-15

{"route": ["ORAL"], "spl_id": "1b47473e-6644-4026-90e5-b169fce62b60", "openfda": {"nui": ["N0000008486", "N0000185506", "N0000182140"], "upc": ["0369097817039", "0369097818036", "0369097816032", "0369097819033"], "unii": ["0H73WJJ391"], "rxcui": ["151226", "199888", "199889", "199890"], "spl_set_id": ["4087eb3c-96e9-4d0a-b80b-663e1c86d256"], "pharm_class_pe": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "pharm_class_moa": ["Cytochrome P450 3A4 Inducers [MoA]", "Cytochrome P450 2C19 Inhibitors [MoA]"], "manufacturer_name": ["Cipla USA Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "60 TABLET in 1 BOTTLE (69097-819-03)", "package_ndc": "69097-819-03", "marketing_start_date": "20160722"}, {"sample": false, "description": "500 TABLET in 1 BOTTLE (69097-819-12)", "package_ndc": "69097-819-12", "marketing_start_date": "20160722"}, {"sample": false, "description": "1000 TABLET in 1 BOTTLE (69097-819-15)", "package_ndc": "69097-819-15", "marketing_start_date": "20160722"}], "brand_name": "Topiramate", "product_id": "69097-819_1b47473e-6644-4026-90e5-b169fce62b60", "dosage_form": "TABLET", "pharm_class": ["Cytochrome P450 2C19 Inhibitors [MoA]", "Cytochrome P450 3A4 Inducers [MoA]", "Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "product_ndc": "69097-819", "generic_name": "Topiramate", "labeler_name": "Cipla USA Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Topiramate", "active_ingredients": [{"name": "TOPIRAMATE", "strength": "200 mg/1"}], "application_number": "ANDA079162", "marketing_category": "ANDA", "marketing_start_date": "20160722", "listing_expiration_date": "20261231"}